These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 10449165

  • 1. Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens.
    Grufman P, Sandberg JK, Wolpert EZ, Kärre K.
    J Leukoc Biol; 1999 Aug; 66(2):268-71. PubMed ID: 10449165
    [Abstract] [Full Text] [Related]

  • 2. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.
    Wolpert EZ, Grufman P, Sandberg JK, Tegnesjö A, Kärre K.
    J Immunol; 1998 Nov 01; 161(9):4499-505. PubMed ID: 9794374
    [Abstract] [Full Text] [Related]

  • 3. T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigens.
    Grufman P, Wolpert EZ, Sandberg JK, Kärre K.
    Eur J Immunol; 1999 Jul 01; 29(7):2197-204. PubMed ID: 10427982
    [Abstract] [Full Text] [Related]

  • 4. Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides.
    Wolpert E, Franksson L, Kärre K.
    Int Immunol; 1995 Jun 01; 7(6):919-28. PubMed ID: 7577800
    [Abstract] [Full Text] [Related]

  • 5. Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens.
    Yin L, Poirier G, Neth O, Hsuan JJ, Totty NF, Stauss HJ.
    Int Immunol; 1993 Sep 01; 5(9):1003-9. PubMed ID: 7694638
    [Abstract] [Full Text] [Related]

  • 6. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
    Pion S, Fontaine P, Desaulniers M, Jutras J, Filep JG, Perreault C.
    Eur J Immunol; 1997 Feb 01; 27(2):421-30. PubMed ID: 9045913
    [Abstract] [Full Text] [Related]

  • 7. Immunodominant minor histocompatibility antigen peptides presented by H2Db molecules.
    Nevala WK, Wettstein PJ.
    Transplantation; 1997 Nov 15; 64(9):1323-30. PubMed ID: 9371675
    [Abstract] [Full Text] [Related]

  • 8. Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.
    Rodriguez F, Harkins S, Slifka MK, Whitton JL.
    J Virol; 2002 May 15; 76(9):4251-9. PubMed ID: 11932390
    [Abstract] [Full Text] [Related]

  • 9. Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.
    Dinter J, Duong E, Lai NY, Berberich MJ, Kourjian G, Bracho-Sanchez E, Chu D, Su H, Zhang SC, Le Gall S.
    PLoS Pathog; 2015 Mar 15; 11(3):e1004725. PubMed ID: 25781895
    [Abstract] [Full Text] [Related]

  • 10. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
    Korngold R, Leighton C, Mobraaten LE, Berger MA.
    Biol Blood Marrow Transplant; 1997 Jun 15; 3(2):57-64. PubMed ID: 9267665
    [Abstract] [Full Text] [Related]

  • 11. Avidity of CD8 T cells sharpens immunodominance.
    Dzutsev AH, Belyakov IM, Isakov DV, Margulies DH, Berzofsky JA.
    Int Immunol; 2007 Apr 15; 19(4):497-507. PubMed ID: 17376783
    [Abstract] [Full Text] [Related]

  • 12. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M, Wettstein PJ, Korngold R.
    Transplantation; 1994 Apr 15; 57(7):1095-102. PubMed ID: 7909395
    [Abstract] [Full Text] [Related]

  • 13. Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation.
    Nevala WK, Paul C, Wettstein PJ.
    Transplantation; 1998 Feb 27; 65(4):559-69. PubMed ID: 9500633
    [Abstract] [Full Text] [Related]

  • 14. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P, Hutchinson SC, Mylin LM, Tevethia MJ, Tevethia SS, Schell TD.
    J Immunol; 2005 Jul 15; 175(2):700-12. PubMed ID: 16002665
    [Abstract] [Full Text] [Related]

  • 15. The preferential cytolytic T lymphocyte response to immunodominant minor histocompatibility antigen peptides.
    Nevala WK, Wettstein PJ.
    Transplantation; 1996 Jul 27; 62(2):283-91. PubMed ID: 8755829
    [Abstract] [Full Text] [Related]

  • 16. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG, Sette A, Oseroff C, Alexander J, Murali-Krishna K, Lau LL, Southwood S, Sidney J, Chesnut RW, Matloubian M, Ahmed R.
    J Immunol; 1996 Dec 15; 157(12):5543-54. PubMed ID: 8955205
    [Abstract] [Full Text] [Related]

  • 17. Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses.
    Choi J, Meilleur CE, Haeryfar SMM.
    J Vis Exp; 2019 May 06; (147):. PubMed ID: 31107454
    [Abstract] [Full Text] [Related]

  • 18. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
    Schirmbeck R, Stober D, El-Kholy S, Riedl P, Reimann J.
    J Immunol; 2002 Jun 15; 168(12):6253-62. PubMed ID: 12055239
    [Abstract] [Full Text] [Related]

  • 19. Immunodominant CD4+ T cell receptor Vbeta repertoires involved in graft-versus-host disease responses to minor histocompatibility antigens.
    Berger MA, Korngold R.
    J Immunol; 1997 Jul 01; 159(1):77-85. PubMed ID: 9200441
    [Abstract] [Full Text] [Related]

  • 20. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others.
    Choi EY, Yoshimura Y, Christianson GJ, Sproule TJ, Malarkannan S, Shastri N, Joyce S, Roopenian DC.
    J Immunol; 2001 Apr 01; 166(7):4370-9. PubMed ID: 11254691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.